C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,779 | -61.6% | 12,350 | -27.8% | 0.02% | -60.4% |
| Q4 2022 | $100,902 | -40.3% | 17,102 | -11.4% | 0.05% | -20.9% |
| Q3 2022 | $169,000 | +16.6% | 19,305 | +0.7% | 0.07% | +24.1% |
| Q2 2022 | $145,000 | +13.3% | 19,169 | +263.4% | 0.05% | -5.3% |
| Q1 2022 | $128,000 | -28.9% | 5,275 | -5.6% | 0.06% | -16.2% |
| Q4 2021 | $180,000 | -20.0% | 5,589 | +10.8% | 0.07% | -31.3% |
| Q3 2021 | $225,000 | +11.9% | 5,043 | -5.1% | 0.10% | +19.3% |
| Q2 2021 | $201,000 | – | 5,312 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |